Trial Profile
Phase I study of remimazolam to determine number of patients required for EU phase III study in general anesthesia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2017
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications General anaesthesia
- Focus Therapeutic Use
- 16 Aug 2017 New trial record
- 09 Aug 2017 According to a PAION media release, this study will determine the number of patients required for a EU Phase III study in general anesthesia and the company expected this study to be completed in the fourth quarter of 2017.